Consider alternative therapies, if available
This dose is used for both initial treatment and ongoing therapy
Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The essentials for running any reconstituted injectable: cold storage, accurate syringes, alcohol prep pads, and metabolic tracking
These products are not for human or animal use or consumption in any manner
Carnitine also interacts with the anticonvulsants valproic acid, phenobarbital, phenytoin, or carbamazepine
VeganHealth currently bases the lower range of our recommendations on the U.S